As shown in Fig. 2F, the mRNA expression of TAM characteristic cytokines (IL-10, CCL2, CCL22 and VEGF) were also substantially increased in macrophages incubated with CM from HCC cells pre-treated with sorafenib. This evidence concerns the gene CCL22 and hepatocellular carcinoma.